PMC:7195088 / 15989-16158 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"740","span":{"begin":78,"end":84},"obj":"Chemical"},{"id":"741","span":{"begin":107,"end":111},"obj":"Chemical"}],"attributes":[{"id":"A740","pred":"tao:has_database_id","subj":"740","obj":"MESH:D010100"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Primary endpoint: adverse outcome at day 14 (composite of Spo 2 ≤ 93% without oxygen supplementation, PaO2/FiO2 ≤ 300 mm Hg or respiratory rate ≥ 30 breaths per minute)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T61","span":{"begin":62,"end":68},"obj":"http://purl.obolibrary.org/obo/CLO_0001230"},{"id":"T62","span":{"begin":62,"end":68},"obj":"http://purl.obolibrary.org/obo/CLO_0037237"},{"id":"T63","span":{"begin":62,"end":68},"obj":"http://purl.obolibrary.org/obo/CLO_0050903"},{"id":"T64","span":{"begin":62,"end":68},"obj":"http://purl.obolibrary.org/obo/CLO_0054249"},{"id":"T65","span":{"begin":62,"end":68},"obj":"http://purl.obolibrary.org/obo/CLO_0054250"},{"id":"T66","span":{"begin":62,"end":68},"obj":"http://purl.obolibrary.org/obo/CLO_0054251"},{"id":"T67","span":{"begin":62,"end":68},"obj":"http://purl.obolibrary.org/obo/CLO_0054252"}],"text":"Primary endpoint: adverse outcome at day 14 (composite of Spo 2 ≤ 93% without oxygen supplementation, PaO2/FiO2 ≤ 300 mm Hg or respiratory rate ≥ 30 breaths per minute)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T97","span":{"begin":78,"end":84},"obj":"Chemical"},{"id":"T98","span":{"begin":121,"end":123},"obj":"Chemical"}],"attributes":[{"id":"A97","pred":"chebi_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"},{"id":"A98","pred":"chebi_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/CHEBI_16170"},{"id":"A99","pred":"chebi_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/CHEBI_25195"}],"text":"Primary endpoint: adverse outcome at day 14 (composite of Spo 2 ≤ 93% without oxygen supplementation, PaO2/FiO2 ≤ 300 mm Hg or respiratory rate ≥ 30 breaths per minute)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T101","span":{"begin":0,"end":169},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Primary endpoint: adverse outcome at day 14 (composite of Spo 2 ≤ 93% without oxygen supplementation, PaO2/FiO2 ≤ 300 mm Hg or respiratory rate ≥ 30 breaths per minute)."}